Growth Stage Impact Companies
Specializing in Research and Development (R&D) activities, accredited by the National Research Agency (ANI), seeking funding for R&D.
Pure Equity
€2 million with target returns of 10%-30%.
Growth Stage Impact Companies
Specializing in Research and Development (R&D) activities, accredited by the National Research Agency (ANI), seeking funding for R&D.
Pure Equity
€2 million with target returns of 10%-30%.
Mature Stage Impact Companies
With positive recurring EBITDA
Hybrid with 10% Equity + 90% Convertibles
€1 million with target returns of 0%-15%
We would like to talk to you.
Book a conversation with our team and explore global investment diversification opportunities focusing on Golden Visa.